Lingling Wang et al. 2020. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway. Turkish Journal of Gastroenterology. 31, 12 (May 2020), 902–909.